25 June 2020: The concept of “vigilance” in clinical trials expands the boundaries

from drug experience to medical device. The normative background, language and modes of action: comparing experiences An interactive seminar, albeit in webinar mode, during which we will go through the requirements of pharmacovigilance in clinical trials in brief pills, and then hook the imminent need to adapt the activity of "vigilance" also to the medical device. The speakers will refer to the current regulations, and then share with the participants direct experiences and offer a multi-faceted panorama faced by different actors: the CRO, the Sponsor, the CTC in support of independent research [...]